Table 5.
Comparison of pathogenic mutation sites in preoperative stools vs tumor tissues
| Gene |
Positive rate of pathogenic gene mutation sites
|
|
|
Preoperative feces
|
Tumor tissues
|
|
| TP53 | 37.04% (10/27) | 46.00% (23/50) |
| APC | 11.11% (3/27) | 18.00% (9/50) |
| KRAS | 25.93% (7/27) | 54.00% (27/50) |
| PIK3CA | 3.70% (1/27) | 22.00% (11/50) |
| FBXW7 | 3.70% (1/27) | 6.00% (3/50) |
| GNAS | 3.70% (1/27) | 4.00% (2/50) |
| PTEN | 3.70% (1/27) | 0 |
| ABL1 | 3.70% (1/27) | 0 |
| PDGFRA | 3.70% (1/27) | 0 |
| ATM | 0 | 2.00% (1/50) |
| SMAD4 | 0 | 2.00% (1/50) |
| BRAF | 0 | 2.00% (1/50) |
| PTPN11 | 0 | 2.00% (1/50) |
| NRAS | 0 | 2.00% (1/50) |
| CTNNB1 | 0 | 2.00% (1/50) |
| VHL | 3.70% (1/27) | 0 |
Positive rate of pathogenic gene mutation site: The number of people with mutations corresponding to the pathogenic mutation sites of any gene/total number of samples.